The Phase III human clinical trials of COVAXIN which began mid-November targeted to be done in 26,000 volunteers across India. This is India’s first and only Phase III efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India.
https://ift.tt/eA8V8J The Phase III human clinical trials of COVAXIN which began mid-November targeted to be done in 26,000 volunteers across India. This is India’s first and only Phase III efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted for any vaccine in India. from Zee News :India National https://ift.tt/3azXVqC
Home »
Zee News :India National
» Covaxin crosses half-way mark in phase 3 clinical trials with 13,000 volunteers
Covaxin crosses half-way mark in phase 3 clinical trials with 13,000 volunteers

No comments:
Post a Comment